Rights issues in Indian markets just hit a 28-year high. In 2025, 42 companies raised ₹43,906 crore through rights issues — more than double the 19 companies that did so the previous year. SEBI’s revised rights issue framework accelerated the process, cutting timelines and making it the preferred fundraising route precisely when QIPs shrank due to broader market correction.
Most retail investors who hold shares in a rights-issuing company face the same moment of confusion: a rights entitlement lands in their demat account, and they have no clear framework for what to do with it. Subscribe and pay more? Sell the rights? Ignore them entirely?
Each choice has a real financial consequence. Understanding which is correct in a given situation requires understanding what a rights issue actually signals — and it doesn’t always signal the same thing.
What a Rights Issue Is and Why Companies Use It Now
A rights issue gives existing shareholders the right — not the obligation — to buy additional shares at a fixed price, in a fixed ratio, within a specified subscription window. The price is set at a discount to the current market price to incentivise participation.
A company issuing 1:2 rights at ₹150 when the stock trades at ₹200 is offering you one new share for every two you hold at a 25% discount. On paper, that looks attractive. The real question is always what the company plans to do with that capital.
Rights issues spiked in 2025 for a specific reason. QIPs — the faster institutional fundraising route — shrank because falling markets compressed valuations below what companies were willing to accept from institutional investors. Rights issues, by contrast, let companies raise capital directly from their own shareholders who already believe in the business. The shareholder base provides the capital precisely because they have conviction the stock market currently lacks.
That context matters. A rights issue in a correcting market, from a fundamentally sound company, at a meaningful discount to fair value, is a genuinely good opportunity for existing shareholders. A rights issue from a company in financial distress, raising capital to service debt or cover operating losses, is a different situation entirely.
The Three Choices — and What Each One Actually Means
Every rights issue creates three options for existing shareholders.
Subscribe fully. You pay the rights price and receive the additional shares. This makes sense when you believe in the company’s fundamental story, the capital is being deployed productively — expansion, debt reduction on good assets, an acquisition with clear logic — and the rights price represents genuine value relative to fair value. Subscribing to a rights issue of a company you understand and trust is one of the few times Indian retail investors get institutional-style access to new shares at a discount.
Sell the rights entitlement. Rights entitlements now trade on NSE and BSE exchanges from the date they’re credited to your demat account. If you don’t want to invest more capital but don’t want to simply lose value, you can sell your rights entitlement during the trading window. The market prices the entitlement based on the discount embedded in the rights price. This option makes sense when you’re uncertain about the capital deployment, don’t have the available funds, or think the market’s current enthusiasm for the rights exceeds the underlying value.
Let the rights lapse. This is the worst outcome for almost every retail investor in almost every situation. Letting rights lapse means your ownership percentage in the company decreases as other shareholders subscribe and new shares get issued to them. You’ve been diluted without receiving any compensation. The only scenario where letting rights lapse makes rational sense is when you’ve already decided to exit the stock entirely and selling shares in the market produces a better outcome than the rights mechanics.
QIP vs Rights Issue — Reading the Signal Correctly
When a company chooses between a QIP and a rights issue, that choice itself carries information.
A QIP means the company wants institutional investors quickly. It happens in three to seven days, requires no SEBI pre-approval, and dilutes retail shareholders without giving them participation rights. Brookfield India REIT raised ₹2,600 crore via QIP in April 2026, backed by IFC, HDFC Life, and Axis Max Life. The institutional validation was the signal — credible long-term investors buying at a negotiated price signals fundamental confidence.
But retail investors in that QIP? They weren’t invited. Their ownership percentage diluted the moment new shares got allotted to institutions. The QIP discount — typically 3-7% below market price — went to institutions, not to the existing shareholders who built the company’s investor base.
A rights issue does the opposite. It extends the capital raise to existing shareholders first. In a rights issue, the discount goes to you if you choose to participate. The dilution happens only if you choose not to.
When a company that could have done a QIP chooses a rights issue instead, it sometimes signals that institutional appetite for the stock is limited — institutions wouldn’t subscribe at the price needed. When a company in a corrected market uses rights issues to raise capital from committed shareholders rather than institutional investors at distressed valuations, it can signal management conviction in the recovery story.
Neither interpretation is automatic. Both deserve investigation.
What Changed Under SEBI’s 2025 Rights Issue Framework
SEBI’s revised rights issue framework eliminated several friction points that previously slowed the process and deterred retail participation.
Rights entitlements now trade on exchanges from the moment they’re credited, giving shareholders a genuine secondary market option that didn’t exist cleanly before. The window for renouncing rights — selling your entitlement to someone else — expanded meaningfully.
The accelerated timeline means rights issues now close faster than before. Shareholders need to act promptly once the entitlement lands in their demat. Procrastinating through the subscription window and then discovering the lapse date has passed is now a more expensive mistake because of the tradeable entitlement value being forfeited.
One Clear Framework for Any Rights Issue Decision
When rights land in your demat account, three questions determine the right response.
Do you still believe in this company’s fundamental story? If yes, consider subscribing. If no, the rights issue is not the mechanism to re-evaluate that conviction — sell the shares, not just the rights.
What is the capital being raised for? Productive expansion and debt reduction on strong assets justify subscription. Plugging operating losses and refinancing distressed group entities do not.
Can you actually afford to subscribe without straining your overall portfolio allocation? Rights issues that force you to overweight a single stock beyond your risk tolerance are a bad deal at any discount.
Rights issues in Indian markets are neither automatically good nor automatically bad. They’re information about a company’s capital needs at a specific moment — and a decision point that most retail investors approach without a framework.
That framework is what determines who captures the discount and who gets diluted.
This content is for educational purposes only and does not constitute financial or investment advice.